Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Evolving Treatment Options in First-line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
Release Date:
Partner: Astellas
Review Process: Pfizer Internal
Education Oncology All
Promoting Understanding of COVID-19 and Vaccination and Improving Communication Skills for Healthcare Professionals
Release Date:
Review Process: Expert Review Panel
Translation: Japanese (link)
Quality Improvement Vaccines Japan
American Headache Society Quality Improvement Competitive Grant Program
Release Date:
Partner: American Headache Society
Review Process: Expert Review Panel
Quality Improvement Internal Medicine USA
Boosting Oncology Opportunities for Support programs and Treatment, (BOOST), An Oncology Quality Boosting Program
Release Date:
Review Process: Expert Review Panel
Translation:(link)
Quality Improvement Oncology Netherlands
Investigator Sponsored Research for Understanding the Mechanisms and Formulating the Optimal Management of Hematological Toxicit
Release Date:
Partner: National Comprehensive Cancer Network
Review Process: Expert Review Panel
Research Oncology USA
Improving Care for Patients with Recurrent/Metastatic (R/M) Cervical Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Real-World Clinical Outcomes Among Adult and Adolescent Patients with Severe Alopecia Areata Receiving Ritlecitinib in China
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Title
Grant Type
Focus Area
Country
Application Due Date
Updates in RSV Prevention for Prenatal Care Workers Serving Marginalized Communities
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Acquired Aplastic Anemia: Educational programs to upskill hematologists & primary care physicians with current best practices
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Bridging the Inflammatory Dermatosis Care Divide with Teledermatology
Release Date:
Partner: The George Washington University
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology USA
Knowledge Gaps in Drug-Drug Interactions in COVID-19 Outpatient Treatment
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Optimizing COVID-19 Treatment Strategies in Elderly Vulnerable Populations in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Vaccines Canada
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Rare Disease Canada
Improving access to and the quality of clinical diagnostic solutions (Africa Geographic Scope)
Release Date:
Review Process: Pfizer Internal
Quality Improvement Support for the Professions All
Patient Education and Support for the Management of Migraine
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine All
Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism (ex-US)
Release Date:
Partner: Bristol-Myers Squibb
Review Process: Pfizer Internal
Education Internal Medicine All
Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
Review Process: Expert Review Panel
Quality Improvement Rare Disease All
Accord for a Healthier World: Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
Release Date:
Review Process: Pfizer Internal
Quality Improvement Hospital Malawi, Rwanda, Senegal
Updates in Post-COVID Conditions: Potential Causes, Assessment, Testing, Management, and Ongoing Research
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA